Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus.

about

The Role of Autoantibodies in Bone Metabolism and Bone Loss.

P2860

Q47331159-EF865042-62D7-48FC-9E02-64A3B4618771

P2860

Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus.

Item

http://www.wikidata.org/entity/Q47952057

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus.

@en

Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus.

@nl

type

Item

label

Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus.

@en

Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus.

@nl

prefLabel

Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus.

@en

Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus.

@nl

P1476

Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus

@en

P2093

Irene E M Bultink

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Frailty in older adults: evidence for a phenotype

Bone metabolism and bone mineral density of systemic lupus erythematosus at the time of diagnosis

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population data.

Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study.

Factors associated with low bone mineral density in female patients with systemic lupus erythematosus.

Lupus nephritis.

Prevalence and risk factors of vertebral compression fractures in female SLE patients.

European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies

Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators

P2888

s00223-017-0322-z

P304

575-591

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00223-017-0322-Z

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Irene E. Bultink

P5008

ScienceSource

P577

2017-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28900675

http://www.w3.org/2001/XMLSchema#string

P921

systemic lupus erythematosus

osteoporosis

connective tissue disease

connective tissue

metabolic bone disease

P932

5904226

http://www.w3.org/2001/XMLSchema#string

Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus.

about

P2860

P2860

Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P5008

P577

P698

P921

P932